Literature DB >> 190895

Prostaglandins in adrenergic transmission of isolated perfused rat pancreas.

M Hamamdzić, K U Malik.   

Abstract

In the isolated, perfused rat pancreas, prostaglandins (PGs) E1 and E2 1-5 ng/ml, reduced the vasoconstrictor responses to periarterial nerve stimulation and variably affected those to injected norepinephrine. Prostaglandin F2alpha had no consistent effect on the vasoconstrictor responses to both adrenergic stimuli. Stimulation of adrenergic nerves or administration of norepinephrine released a PGE-like substance from the perfused pancreas which was abolished by inhibitors of PG synthesis, acetylsalicylic acid, indomethacin, meclofenamate, and eicosa-5,8,11,14-tetraynoic acid. The latter three agents did not potentiate, but rather reduced the vasoconstrictor responses to both adrenergic stimuli. Arachidonic acid that was converted by the pancreas into PGE2 and PGF2alpha inhibited the vasoconstrictor responses to adrenergic stimuli. The latter effect of arachidonic acid was not altered by the simultaneous infusion of PG synthetase inhibitors. Although these results, which could be attributed to a direct effect of inhibitors of PG synthesis and arachidonic acid on adrenergic neuroeffector junction, fail to establish the role of endogenous PGs in modulating adrenergic responses in rat pancreatic vessels, they emphasize the differences in the effect of PGE1 and PGE2 on adrenergic responses in various vascular beds of the rat.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190895     DOI: 10.1152/ajpendo.1977.232.2.E201

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Prostaglandin action, release and inactivation by rat isolated perfused mesenteric blood vessels.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

2.  Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog.

Authors:  R P Robertson; R J Guest
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.